Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,243.00
Bid: 1,244.80
Ask: 1,245.80
Change: 18.80 (1.54%)
Spread: 1.00 (0.08%)
Open: 1,212.40
High: 1,247.00
Low: 1,210.80
Yest. Close: 1,224.20
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Thursday broker round-up

(Sharecast News) - GSK: Deutsche Bank downgrades to sell with a target price of 1,150p.

4 Feb 21 12:55

BROKER RATINGS: GlaxoSmithKline Gets Two Downgrades; Prudential Raised

BROKER RATINGS: GlaxoSmithKline Gets Two Downgrades; Prudential Raised

4 Feb 21 09:27

LONDON BRIEFING: Newly Unified Unilever Sets Out Growth Ambitions

LONDON BRIEFING: Newly Unified Unilever Sets Out Growth Ambitions

4 Feb 21 08:21

LONDON MARKET CLOSE: Rising Oil Majors Help Offset Sinking Glaxo

LONDON MARKET CLOSE: Rising Oil Majors Help Offset Sinking Glaxo

3 Feb 21 16:58

UPDATE 1-GSK sees lower profit this year, split plans on track

(Adds details, background)Feb 3 (Reuters) - Britain's GSK forecast a dip in earnings this year as it grapples with COVID-19 disruptions and invests in its pipeline of new drugs, and said its plans to split into two businesses were on track.The wor...

3 Feb 21 12:24

UPDATE 2-GSK sees lower profit this year as COVID-19 disruptions drag on

* Sees mid-to-high single digit fall in 2021 earnings* Pressured by COVID-19 disruptions, investment* Split into two companies on track* Shares fall around 3% (Adds detail, background)By Pushkala Aripaka and Ludwig BurgerFeb 3 (Reuters) - GSK warned...

3 Feb 21 12:24

UPDATE 3-GSK sees lower profit as COVID-19 disruptions drag on

* Sees mid-to-high single digit fall in 2021 earnings* Pressured by COVID-19 disruptions, investment* Split into two companies on track* Shares fall as much as 5% (Adds CEO comments from media call, link to breakingviews)By Pushkala Aripaka and Ludw...

3 Feb 21 12:24

GlaxoSmithKline forecasts decline in 2021 earnings, shares slump

(Sharecast News) - Shares of GlaxoSmithKline slumped on Wednesday after the pharmaceuticals giant said it expects 2021 earnings to decline, as it reported growth in revenues and profit for 2020.

3 Feb 21 12:11

LONDON MARKET MIDDAY: AstraZeneca And Glaxo Give Markets Vaccine Lift

LONDON MARKET MIDDAY: AstraZeneca And Glaxo Give Markets Vaccine Lift

3 Feb 21 12:03

TOP NEWS SUMMARY: Vaccine Hope From GlaxoSmithKline And AstraZeneca

TOP NEWS SUMMARY: Vaccine Hope From GlaxoSmithKline And AstraZeneca

3 Feb 21 11:35

UPDATE 2-Italian shares jump on Draghi hope; GSK weighs on FTSE 100

* Milan stocks rise on hopes of Draghi becoming next PM* Daimler jumps on plan to spin-off truck business* GSK slides; warns of bigger than expected fall in 2021 earnings (Updates to close)By Shreyashi Sanyal and Susan MathewFeb 3 (Reuters) - Itali...

3 Feb 21 09:18

UPDATE 2-Healthcare drags FTSE 100 down; Vodafone jumps

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* GlaxoSmithKline slumps on COVID-19 vaccine development* Vodafone gains after earnings beat estimates* Glencore rises after maintaining 2021...

3 Feb 21 09:17

LONDON MARKET OPEN: Glaxo To Co-Develop Covid Vaccine; Vodafone Rises

LONDON MARKET OPEN: Glaxo To Co-Develop Covid Vaccine; Vodafone Rises

3 Feb 21 08:47

LONDON BRIEFING: Glaxo Joins CureVac To Fight Covid-19 Variants

LONDON BRIEFING: Glaxo Joins CureVac To Fight Covid-19 Variants

3 Feb 21 08:20

LONDON MARKET PRE-OPEN: GlaxoSmithKline, CureVac Team For Covid-19 Jab

LONDON MARKET PRE-OPEN: GlaxoSmithKline, CureVac Team For Covid-19 Jab

3 Feb 21 07:48

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.